A Hierarchical Framework for In Vitro Models of Alzheimer's Disease
WIREs Mechanisms of Disease · 2026
DOI: 10.1002/wsbm.70015 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift WIREs Mechanisms of Disease, 2026. Verfasst von Florencia B Balverde-Caballero und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unitat de Genètica Molecular, Institut de Biomedicina de València-CSIC, València, Spain. Hauptthemen laut MEDLINE: Alzheimer Disease, Models, Biological. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas ISCIII. Ministerio de Ciencia, Innovación y Universidades.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) remains a major global health challenge, with a high rate of clinical trial failures often attributed to the limited translational predictive value of traditional experimental models. In vitro systems, ranging from induced pluripotent stem cell (iPSC)‐derived neurons to complex three‐dimensional (3D) organoids, have emerged as promising alternatives to investigate disease mechanisms in a controlled experimental setting. However, their rapid expansion has generated fragmented nomenclature and heterogeneous classification schemes. In this systematic review, we propose a hierarchical framework that categorizes in vitro AD models according to their architectural complexity and the biological questions they are designed to address. We organize these platforms into four progressive tiers: genetically defined iPSC‐derived cell‐autonomous models, stimulus‐based reductionist models, interaction‐dependent neuron–glia co‐cultures, and advanced multicellular 3D or neurovascular platforms. Our findings indicate that low complexity models (Tier 1 and Tier 2) are particularly suited to dissect cell‐intrinsic genetic drivers and acute toxic signaling, but they often fail to capture the chronic multicellular feedback loops and vascular dysfunction characteristic of AD. In contrast, high‐complexity systems (Tier 3 and Tier 4), including organ‐on‐chip platforms and vascularized organoids, provide the spatial and physiological context necessary to model neuroinflammation and network‐level degeneration, although they present greater technical variability. Finally, we propose an integrative hierarchical strategy that aligns model selection with specific pathological questions. By linking cellular complexity with mechanistic objectives, this framework provides a structured roadmap to improve experimental rigor, facilitate cross‐study comparability, and support the development of more predictive experimental models for AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Unitat de Genètica Molecular, Institut de Biomedicina de València-CSIC, València, Spain.
- CIBERNED, ISCIII, València, Spain.
- Departamento de Biotecnología, Universitat Politècnica de València, Valencia, Spain.
ORCID-Profile: Florencia B Balverde-Caballero, Jordi Pérez-Tur, Fernando Cardona
Förderung
- Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas ISCIII. Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Balverde-Caballero, F. B., Pérez-Tur, J., & Cardona, F. (2026). A Hierarchical Framework for In Vitro Models of Alzheimer's Disease. WIREs Mechanisms of Disease. https://doi.org/10.1002/wsbm.70015
Vancouver
Balverde-Caballero FB, Pérez-Tur J, Cardona F. A Hierarchical Framework for In Vitro Models of Alzheimer's Disease. WIREs Mechanisms of Disease. 2026. doi:10.1002/wsbm.70015
BibTeX
@article{BalverdeCaballero2026,
author = {Balverde-Caballero, Florencia B and Pérez-Tur, Jordi and Cardona, Fernando},
title = {A Hierarchical Framework for In Vitro Models of Alzheimer's Disease},
journal = {WIREs Mechanisms of Disease},
year = {2026},
doi = {10.1002/wsbm.70015}
}
EUVIMED